Differentiation antagonizing non-protein coding RNA (DANCR)

Differentiation antagonizing non-protein coding RNA (DANCR) is a long non-coding RNA, originally identified as an inhibitor of epithelial differentiation. It is notably upregulated in many cancer types, where it drives malignancy by promoting proliferation, migration, invasion, metastasis, and inhibiting apoptosis. Mechanistically, DANCR functions via binding chromatin modifiers (e.g., EZH2), acting as a sponge for multiple microRNAs, stabilizing oncogene mRNAs through protein interactions (e.g., NF90/NF45), and activating key oncogenic pathways (e.g., STAT3, AKT-PI3K). DANCR’s expression correlates with poor prognosis and chemoresistance and is considered a potential biomarker and therapeutic target, with its levels detectable in patient blood and exosomes. The complexity of its regulatory functions across tissues and its emergence as an epigenetic cancer driver mark it as both a promising clinical target and a molecule warranting careful therapeutic consideration.

Other names

ANCRSNHG13KIAA0114lncRNA-ANCRAnti-differentiation ncRNAputative uncharacterized protein DANCRAnti-differentiation noncoding RNASmall nucleolar RNA host gene 13adipogenesis up-regulated transcript 2AGU2

Acts as a molecular sponge for microRNAs (multiple such as miR-758-3p, miR-138). Binds to chromatin modifiers like EZH2 to effect histone methylation and epigenetic gene silencing. Stabilizes mRNAs of oncogenes or drug resistance genes via interaction with RNA-binding proteins (e.g., NF90/NF45 complex). Positive feedback activation of oncogenic pathways (STAT3 phosphorylation, PI3K/AKT signaling).